Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
The American Review of Respiratory Disease
|
January 1, 1985
Relation of arachidonate metabolites to abnormal control of the pulmonary circulation in a child
R J Barst, S A Stalcup, C N Steeg, et al.
The European Respiratory Journal
|
February 3, 2005
Survival with first-line bosentan in patients with primary pulmonary hypertension
V V McLaughlin, O Sitbon, D B Badesch, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 11, 2000
Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33
Z Deng, F Haghighi, L Helleby, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
September 1, 1996
Feasibility of a two-dimensional echocardiographic method for the clinical assessment of right ventricular volume and function in children
H D Apfel, D E Solowiejczyk, B F Printz, et al.
The European Respiratory Journal
|
September 11, 2004
BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease
K E Roberts, J J McElroy, W P K Wong, et al.
The European Respiratory Journal
|
April 7, 2004
Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia
S A Abdalla, C J Gallione, R J Barst, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 1, 1997
Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7
J H Morse, R J Barst, M Fotino, et al.
The Journal of Vascular Access
|
October 5, 2006
Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension
V F Tapson, V V McLaughlin, M Gomberg-Maitland, et al.
Thorax
|
August 2, 2005
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
O Sitbon, V V McLaughlin, D B Badesch, et al.
The European Respiratory Journal
|
September 11, 2004
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2
M Humbert, R J Barst, I M Robbins, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
The American Review of Respiratory Disease
|
January 1, 1985
Relation of arachidonate metabolites to abnormal control of the pulmonary circulation in a child
R J Barst, S A Stalcup, C N Steeg, et al.
The European Respiratory Journal
|
February 3, 2005
Survival with first-line bosentan in patients with primary pulmonary hypertension
V V McLaughlin, O Sitbon, D B Badesch, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 11, 2000
Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33
Z Deng, F Haghighi, L Helleby, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
September 1, 1996
Feasibility of a two-dimensional echocardiographic method for the clinical assessment of right ventricular volume and function in children
H D Apfel, D E Solowiejczyk, B F Printz, et al.
The European Respiratory Journal
|
September 11, 2004
BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease
K E Roberts, J J McElroy, W P K Wong, et al.
The European Respiratory Journal
|
April 7, 2004
Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia
S A Abdalla, C J Gallione, R J Barst, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 1, 1997
Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7
J H Morse, R J Barst, M Fotino, et al.
The Journal of Vascular Access
|
October 5, 2006
Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension
V F Tapson, V V McLaughlin, M Gomberg-Maitland, et al.
Thorax
|
August 2, 2005
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
O Sitbon, V V McLaughlin, D B Badesch, et al.
The European Respiratory Journal
|
September 11, 2004
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2
M Humbert, R J Barst, I M Robbins, et al.
Page
of 8